A significant breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This vital tumor inhibitor protein is frequently disabled in several types of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research